drugset / Trial / NCT07820891
A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will enroll healthy participants to evaluate whether BGB-43395 interacts with other drugs, including midazolam, celecoxib, dabigatran, and rosuvastatin.
Timeline
- Start
- 2026-09-25
- Primary completion
- 2026-11-22
- Completion
- 2026-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGB-43395 | Unknown | — | Oral |
| Subject | Celecoxib | Other / unclassified | — | Oral |
| Subject | Dabigatran etexilate | Unknown | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
Indications
No indication recorded.